These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 34525403)

  • 1. Vertebral osteomyelitis caused by vancomycin-resistant Enterococcus spp.: a case series.
    Russo A; Venditti M
    Int J Antimicrob Agents; 2021 Nov; 58(5):106432. PubMed ID: 34525403
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of Multidrug-Resistant Vancomycin-Resistant Enterococcus faecium Hardware-Associated Vertebral Osteomyelitis with Oritavancin plus Ampicillin.
    Dahesh S; Wong B; Nizet V; Sakoulas G; Tran TT; Aitken SL
    Antimicrob Agents Chemother; 2019 Jul; 63(7):. PubMed ID: 31235559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The importance of adjusting for enterococcus species when assessing the burden of vancomycin resistance: a cohort study including over 1000 cases of enterococcal bloodstream infections.
    Kramer TS; Remschmidt C; Werner S; Behnke M; Schwab F; Werner G; Gastmeier P; Leistner R
    Antimicrob Resist Infect Control; 2018; 7():133. PubMed ID: 30459945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dalbavancin is active in vitro against biofilms formed by dalbavancin-susceptible enterococci.
    Neudorfer K; Schmidt-Malan SM; Patel R
    Diagn Microbiol Infect Dis; 2018 Jan; 90(1):58-63. PubMed ID: 29195766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Linezolid resistance in vancomycin-resistant Enterococcus faecalis and Enterococcus faecium isolates in a Brazilian hospital.
    de Almeida LM; de Araújo MR; Iwasaki MF; Sacramento AG; Rocha D; da Silva LP; Pavez M; de Brito AC; Ito LC; Gales AC; Lincopan N; Sampaio JL; Mamizuka EM
    Antimicrob Agents Chemother; 2014 May; 58(5):2993-4. PubMed ID: 24614366
    [No Abstract]   [Full Text] [Related]  

  • 6. Prolonged linezolid use is associated with the development of linezolid-resistant Enterococcus faecium.
    Smith TT; Tamma PD; Do TB; Dzintars KE; Zhao Y; Cosgrove SE; Avdic E
    Diagn Microbiol Infect Dis; 2018 Jun; 91(2):161-163. PubMed ID: 29496381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vancomycin resistant Enterococci: A brief review.
    Raza T; Ullah SR; Mehmood K; Andleeb S
    J Pak Med Assoc; 2018 May; 68(5):768-772. PubMed ID: 29885179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Continuous and Sequential Therapy among Veterans Receiving Daptomycin or Linezolid for Vancomycin-Resistant Enterococcus faecium Bacteremia.
    Britt NS; Potter EM; Patel N; Steed ME
    Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28264856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment Considerations for CNS Infections Caused by Vancomycin-Resistant
    Lee BJ; Vu BN; Seddon AN; Hodgson HA; Wang SK
    Ann Pharmacother; 2020 Dec; 54(12):1243-1251. PubMed ID: 32506921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the novel combination of daptomycin plus ceftriaxone against vancomycin-resistant enterococci in an in vitro pharmacokinetic/pharmacodynamic simulated endocardial vegetation model.
    Hall Snyder A; Werth BJ; Barber KE; Sakoulas G; Rybak MJ
    J Antimicrob Chemother; 2014 Aug; 69(8):2148-54. PubMed ID: 24777900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 1,2,4-Oxadiazole antimicrobials act synergistically with daptomycin and display rapid kill kinetics against MDR Enterococcus faecium.
    Carter GP; Harjani JR; Li L; Pitcher NP; Nong Y; Riley TV; Williamson DA; Stinear TP; Baell JB; Howden BP
    J Antimicrob Chemother; 2018 Jun; 73(6):1562-1569. PubMed ID: 29518208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial resistance profile of Enterococcus species isolated from intestinal tracts of hospitalized patients in Jimma, Ethiopia.
    Abamecha A; Wondafrash B; Abdissa A
    BMC Res Notes; 2015 Jun; 8():213. PubMed ID: 26036911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ampicillin for the treatment of complicated urinary tract infections caused by vancomycin-resistant Enterococcus spp (VRE): a single-center university hospital experience.
    Shah KJ; Cherabuddi K; Shultz J; Borgert S; Ramphal R; Klinker KP
    Int J Antimicrob Agents; 2018 Jan; 51(1):57-61. PubMed ID: 28666756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing outcomes of adult oncology patients treated with linezolid versus daptomycin for bacteremia due to vancomycin-resistant Enterococcus.
    Patel K; Kabir R; Ahmad S; Allen SL
    J Oncol Pharm Pract; 2016 Apr; 22(2):212-8. PubMed ID: 25326010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. β-Lactams enhance daptomycin activity against vancomycin-resistant Enterococcus faecalis and Enterococcus faecium in in vitro pharmacokinetic/pharmacodynamic models.
    Smith JR; Barber KE; Raut A; Rybak MJ
    Antimicrob Agents Chemother; 2015 May; 59(5):2842-8. PubMed ID: 25753639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of meningitis caused by vancomycin-resistant Enterococcus faecium: high-dose and combination daptomycin therapy.
    Le J; Bookstaver PB; Rudisill CN; Hashem MG; Iqbal R; James CL; Sakoulas G
    Ann Pharmacother; 2010 Dec; 44(12):2001-6. PubMed ID: 21119097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Daptomycin: A viable therapeutic option for vancomycin-resistant enterococcal urinary-tract infections in Indian medical settings?
    Mohan B; Garg S; Appannanavar SB; Taneja N
    Indian J Med Microbiol; 2016; 34(3):398-9. PubMed ID: 27514977
    [No Abstract]   [Full Text] [Related]  

  • 18. Vancomycin-resistant Enterococcus faecium osteomyelitis: successful treatment with quinupristin-dalfopristin.
    Summers M; Misenhimer GR; Antony SJ
    South Med J; 2001 Mar; 94(3):353-5. PubMed ID: 11284529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of tedizolid against Staphylococcus aureus and enterococci with reduced susceptibility to vancomycin, daptomycin or linezolid.
    Barber KE; Smith JR; Raut A; Rybak MJ
    J Antimicrob Chemother; 2016 Jan; 71(1):152-5. PubMed ID: 26476277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Linezolid treatment for osteomyelitis due to vancomycin-resistant Enterococcus faecium.
    Till M; Wixson RL; Pertel PE
    Clin Infect Dis; 2002 May; 34(10):1412-4. PubMed ID: 11981739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.